Immunomodulatory role of opioids in the central nervous system

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 5-6, 1997, Pages 359-366

  Sheng, Wen S ^a   Hu, Shuxian ^a   Gekker, Genya ^a   Zhu, Sheng ^a   Peterson, Phillip K ^a   Chao, Chun C ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Central nervous system; HIV; Immunomodulation; Neurotoxicity; Opioids

Indexed keywords

CHEMOKINE; CYTOKINE; DELTA OPIATE RECEPTOR; FREE RADICAL; KAPPA OPIATE RECEPTOR; LIGAND; MESSENGER RNA; MU OPIATE RECEPTOR; NITRIC OXIDE; OPIATE; OPIATE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; DEGENERATIVE DISEASE; DRUG DEPENDENCE; GLIA CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PHAGOCYTOSIS; SHORT SURVEY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; NARCOTICS; NEUROIMMUNOMODULATION;

EID: 0031415717     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (95)

1. BASKIN D. S., WIDMAYER M. A., BROWNING J. L., HEIZER M. L. and SCHMIDT W. K. (1994): Evaluation of delayed treatment of focal cerebral ischemia with three selective κ-opioid agonists in cats. Stroke, 25, 2047-2054.
2. BOJE K. M. and ARORA P. K. (1992): Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res., 587, 250-256.
3. BRADBURY A. F., SMYTH D. G. and SNELL C. R. (1976): Biosynthetic origin and receptor conformation of methionine enkephalin. Nature, 260, 793-795.
4. BROWNSTEIN M. J. (1993): A brief history of opiates, opioid peptides, and opioid receptors. Proc. Natl. Acad. Sci. USA, 90, 5391-5393.
5. CANQUE B., ROSENZWAJG M., GEY A., TARTOUR E., FRIDMAN W. H. and GLUCKMAN J. C. (1996): Macrophage inflammatory protein-1α is induced by human immunodeficiency virus infection of monocyte-derived macrophages. Blood, 87, 2011-2019.
6. CHAO C. C., ANDERSON W. R., HU S., GEKKER G., MARTELLA A. and PETERSON P. K. (1993): Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin. Immunol. Immunopathol., 67, 178-183.
7. CHAO C. C., GEKKER G., HU S., SHENG W. S., PORTOGHESE P. S. and PETERSON P. K. (1995): Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem. Pharmacol., 50, 715-722.
8. CHAO C. C., GEKKER G., HU S., SHENG W. S., SHARK K. B., BU D. F., ARCHER S., BIDLACK J. M. and PETERSON P. K. (1996): κ-Opioid receptors in human microglia downregulate human immunodeficiency virus-1 expression. Proc. Natl. Acad. Sci. USA, 93, 8051-8056.
9. CHAO C. C., GEKKER G., SHENG W. S., HU S., PORTOGHESE P. S. and PETERSON P. K. (1995): Endogenous opioid peptides suppress cytokine-mediated upregulation of HIV-1 expression in the chronically infected promonocyte clone U1. Adv. Exp. Med. Biol., 373, 65-72.
10. CHAO C. C., GEKKER G., SHENG W. S., HU S., TSANG M. and PETERSON P. K. (1994): Priming effect of morphine on the production of tumor necrosis factor-α by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. J. Pharmacol. Exp. Ther., 269, 198-203.
11. CHAO C. C., HU S., MOLITOR T. W., SHASKAN E. G. and PETERSON P. K. (1992): Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol., 149, 2736-2741.
12. CHAO C. C., HU S., MOLITOR T. W., ZHOU Y., MURTAUGH M. P., TSANG M. and PETERSON P. K. (1992): Morphine potentiates transforming growth factor-β release from human peripheral blood mononuclear cell cultures. J. Pharmacol. Exp. Ther., 262, 19-24.
13. CHAO C. C., HU S. and PETERSON P. K. (1995): Modulation of human microglial cell superoxide production by cytokines. J. Leukoc. Biol., 58, 65-70.
14. CHAO C. C., HU S. and PETERSON P. K. (1996): Potential role of opiates in glia-mediated neurotoxicity. J. Neuroimmunol., 69, 33.
15. CHAO C. C., HU S. and PETERSON P. K. (1996): Opiates, glia, and neurotoxicity. Adv. Exp. Med. Biol., 402, 29-33.
16. CHAO C. C., HU S. and PETERSON P. K. (1996): Glia: the not so innocent bystanders. J. Neurovirol., 2, 234-239.
17. CHAO C. C., HU S., SHARK, K. B., SHENG W. S., GEKKER G. and PETERSON P. K. (1997): Activation of mu opioid receptors inhibits microglial cell chemotaxis. J. Pharmacol. Exp. Ther., 281, 998-1004.
18. CHAO C. C., HU S., SHENG W. S., BU D. F., BUKRINSKY M. I. and PETERSON P. K. (1996): Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. GLIA, 16, 276-284.
19. CHAD C. C., HU S., SHENG W. S., GEKKER G. and PETERSON P. K. (1996): Morphine and murine toxoplasmosis. In FRIEDMAN H., KLEIN T. W. and SPECTER S.: Drugs of abuse, immunity, and infections. CRC Press, New York, 121-128.
20. CHAO C. C., HU S., SHENG W. S. and PETERSON P. K. (1995): Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev. Neurosci., 17, 97-105.
21. CHEN Y., MESTEK A., LIU J., HURLEY J. A. and YU L. (1993): Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol., 44, 8-12.
22. CHOI D. W. and VISESKUL V. (1988): Opioids and non-opioid enantiomers selectively attenuate N-methyl-D-aspartate neurotoxicity on cortical neurons. Eur. J. Pharmacol., 155, 27-35.
23. COLTON C. A. and GILBERT D. L. (1987): Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett., 223, 284-288.
24. 5]-enkephalin on interleukin-1β secretion from microglia in mixed brain cell cultures. J. Neuroimmunol., 62, 9-17.
25. DONNERER J., CARDINALE G., COFFEY J., LISEK C. A., JARDINE I. and SPECTOR S. (1987): Chemical characterization and regulation of endogenous morphine and codeine in the rat. J. Pharmacol. Exp. Ther., 242, 583-587.
26. EVANS C. J., KEITH D. E. JR., MORRISON H., MAGENDZO K. and EDWARDS R. H. (1992): Cloning of a delta opioid receptor by functional expression. Science, 258, 1952-1955.
27. FADEN A. I. (1996): Neurotoxic versus neuroprotective actions of endogenous opioid peptides: implications for treatment of CNS injury. NIDA Res. Monogr., 163, 318-330.
28. GEORGE S. R., ZASTAWNY R. L., BRIONES-URBINA R., CHENG R., NGUYEN T., HEIBER M., KOUVELAS A., CHAN A. S. and O'DOWD B. F. (1994): Distinct distribution of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem. Biophys. Res. Commun., 205, 1438-1444.
29. GILBERT P. E. and MARTIN W. R. (1976): The effects of morphine and nalorphine-like drugs in the nondependent, morphine-dependent and cyclazocine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther., 198, 66-82.
30. GIULIAN D., VACA K. and NOONAN C. A. (1990): Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science, 250, 1593-1596.
31. GOLDSTEIN A., BARRETT R. W., JAMES I. F., LOWNEY L. I., WEITZ C., KNIPMEYER L. L. and RAPOPORT H. (1985): Morphine and other opiates from beef brain and adrenal. Proc. Natl. Acad. Sci. USA, 82, 5203-5207.
32. GOLDSTEIN A. G., FISCHLI W., LOWNEY L. I., HUNKAPILLER M. and HOOD L. (1981): Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc. Natl. Acad. Sci. USA, 78, 7219-7223.
33. GRUBER M. F., WEIH K. A., BOONE E. J., SMITH P. D. and CLOUSE K. A. (1995): Endogenous macrophage CSF production is associated with viral replication in HIV-1 infected human monocyte-derived macrophages. J. Immunol., 154, 5528-5535.
34. HALL E. D., WOLF D. L., ALTHAUS J. S. and VON VOIGTLANDER P. F. (1987): Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injury. Brain Res., 435, 174-180.
35. HAYWARD N. J., MCKNIGHT A. T. and WOODRUFF G. N. (1993): Neuroprotective effect of the κ-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia. Eur. J. Neurosci., 5, 961-967.
36. HU S., SHENG W. S., PETERSON P. K. and CHAO C. C. (1995): Cytokine modulation of murine microglial cell superoxide production. GLIA, 13, 45-50.
37. HU S., SHENG W. S., PETERSON P. K. and CHAO C. C. (1995): Differential regulation by cytokines of human astrocyte nitric oxide production. GLIA, 15, 491-494.
38. HUDSON C. J., VON VOIGTLANDER P. F., ALTHAUS J. S., SCHERCH H. M. and MEANS E. D. (1991): The kappa opioid-related anticonvulsants U-50488H and U-54494A attenuate N-methyl-D-aspartate induced brain injury in the neonatal rat. Brain Res., 564, 261-267.
39. HUGHES J., SMITH T. W., KOSTERLITZ H. W., FOTHERGILL L. A., MORGAN B. A. and MORRIS H. R. (1975): Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature, 258, 577-579.
40. ILYINSKY O. B., KOZLOVA M. V., KONDRIKOVA E. S., KALENTCHUK V. U., TITOV M. I. and BESPALOVA Z. (1987): Effects of opioid peptides and naloxone on nervous tissue in culture. Neuroscience, 22, 719-735.
41. IOANNIDIS J. P., REICHLIN S. and SKOLNIK P. R. (1995): Long-term productive human immunodeficiency virus-1 infection in human infant microglia. Am. J. Pathol., 147, 1200-1206.
42. ITOH J., UKAI M. and KAMEYAMA T. (1993:) U-50,488H, a κ-opioid receptor agonist, markedly prevents memory dysfunctions induced by transient cerebral ischemia in mice. Brain Res., 619, 223-228.
43. IUVONE T., CAPASSO A., D'ACQUISTO F. and CARNUCCIO R. (1995): Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem. Biophys. Res. Commun., 212, 975-980.
44. LEE S. C., DICKSON D. W., BROSNAN C. F. and CASADEVALL A. (1994): Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J. Exp. Med., 180, 365-369.
45. LEE S. C., DICKSON D. W., LIU W. and BROSNAN C. F. (1993): Infection of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-gamma. J. Neuroimmunol., 46, 19-24.
46. LEE S. C., HATCH W. C., LIU W., KRESS Y., LYMAN A. D. and DICKSON D. W. (1993): Productive infection of human fetal microglia by HIV-1. Am. J. Pathol., 143, 1032-1039.
47. LEE S. C., LIU W., DICKSON D. W., BROSNAN C. F. and BERMAN J. W. (1993): Cytokine production by human fetal microglia and astrocytes: differential induction by lipopolysaccharide and IL-1β. J. Immunol., 150, 2659-2667.
48. LYETH B. G. and HAYES R. L. (1992): Cholinergic and opioid mediation of traumatic brain injury. J. Neurotrauma, 9 (suppl. 2), 463-474.
49. SF-162 expression in acutely infected human brain cell cultures. J. Immunol., 158, 2449-2455.
50. LORD J. A. H., WATERFIELD A. A., HUGHES J. and KOSTERLITZ H. W. (1977): Endogenous opioid peptides: Multiple agonists and receptors. Nature, 267, 495-499.
51. LOW K. G., ALLEN R. G. and MELNER M. H. (1992): Differential regulation of proenkephalin expression in astrocytes by cytokines. Endocrinology, 131, 1908-1914.
52. MACKAY K. B., KUSUMOTO D., GRAHAM D. I. and MCCULLOCH J. (1993): Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977. Brain Res., 618, 213-219.
53. MANSOUR A., FOX C. A., AKIL H. and WATSON S. J. (1995): Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci., 18, 22-29.
54. MANSOUR A., KHACHATURIAN H., LEWIS M. E., AKIL H. and WATSON S. J. (1988): Anatomy of CNS opioid receptors. Trends Neurosci., 11, 308-314.
55. 2]deltorphin II in mice: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther., 258, 583-587.
56. MCINTOSH T. K., FERNYAK S., YAMAKAMI I. and FADEN A. I. (1994): Central and systemic κ-opioid agonists exacerbate neurobehavioral response to brain injury in rats. Am. J. Physiol., 267, 665-672.
57. MCINTOSH T. K., HAYES R. L., DEWITT D. S., AGURA V. and FADEN A. I. (1987): Endogenous opioids may mediate secondary damage after experimental brain injury. Am. J. Physiol., 253, 565-574.
58. MCINTOSH T. K., HEAD V. A. and FADEN A. I. (1987): Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat. Brain Res., 225, 225-223.
59. MILLIGAN C. E., WEBSTER L., PIROS E. T., EVANS C. J., CUNNINGHAM T. J. and LEVITT P. (1995): Induction of opioid receptor-mediated macrophage chemotactic activity after neonatal brain injury. J. Immunol., 154, 6571-6581.
60. NEGRO A., TAVELLA A., FACCI L., CALLEGARO L. and SKAPER S. D. (1992): Interleukin-1 beta regulates proenkephalin gene expression in astrocytes cultured from rat cortex. GLIA, 6, 206-212.
61. PATEL N. A., ROMERO A. A., ZADINA J. E. and CHANG S. L. (1996): Chronic exposure to morphine attenuates expression of interleukin-1β in the rat hippocampus. Brain Res., 712, 340-344.
62. PAUL D., BODNAR R. J., GISTRAK M. A. and PASTERNAK G. W. (1989): Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice. Eur. J. Pharmacol., 168, 307-314.
63. PERRY V. H. and GORDON S. (1988): Macrophages and microglia in the nervous system. Trends Neurosci., 11, 273-275.
64. PERT C. and SNYDER S. (1973): Opiate receptor. Demonstration in nervous tissue. Science, 179, 1011-1014.
65. PETERSON P. K., GEKKER G., HU S., ANDERSON W. R., KRAVITZ F., PORTOGHESE P. S., BALFOUR H. H. JR. and CHAO C. C. (1994): Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunol., 50, 167-175.
66. PETERSON P. K., GEKKER G., HU S. and CHAO C. C. (1995): Human astrocytes inhibit intracellular multiplication of Toxoplasma gondii by a nitric oxide-mediated mechanism. J. Infect. Dis., 171, 516-518.
67. PETERSON P. K., GEKKER G., HU S. and CHAO C. C. (1997): Microglia: a "double edged, sword". In PETERSON P. K. and RAMINGTON J. S. (eds.): In defense of the brain: current concepts in the immunopathogenesis and clinical aspects of CNS infections. Blackswell Science, Boston, 31-55.
68. PETERSON P. K., GEKKER G., HU S., SCHOOLOV Y., BALFOUR H. H. JR and CHAO C. C. (1992): Microglial cell upregulation of HIV-1 expression in the chronically infected promonocytic cell line U1: the role of tumor necrosis factor-α. J. Neuroimmunol., 41, 81-88.
69. PETERSON P. K., GEKKER G., HU S., SHENG W. S., MOLITOR T. W. and CHAO C. C. (1995): Morphine stimulates phagocytosis of Mycobacterium tuberculosis by human microglial cells: involvement of a G protein-coupled opiate receptor. Adv. Neuroimmunol., 5, 299-309.
70. PETERSON P. K., GEKKER G., SCHUT R., HU S., BALFOUR H. H. JR. and CHAO C. C. (1993): Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. In FRIEDMAN H., KLEIN T. W. and SPECTER S.: Drugs of abuse, immunity, and AIDS. Plenum Press, New York, 181-188.
71. PETERSON P. K., HU S., ANDERSON W. R. and CHAO C. C. (1994): Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J. Infect. Dis., 170, 457-460.
72. PETERSON P. K., HU S., SALAK-JOHNSON J., MOLITOR T. W. and CHAO C. C. (1997): Differential production of and migratory response to β chemokines by human microglia and astrocytes. J. Infect. Dis. 175, 478-481.
73. PULLIAM L., HERNDIER B. G., TANG N. M. and MCGRATH M. S. (1991): Human immunodeficiency virus-infected macrophages produce soluble factors that cause histopathological and neurochemical alterations in cultured human brains. J. Clin. Invest., 87, 503-512.
74. RISDAHL J. M., KHANNA K. V., PETERSON P. K. and MOLITOR T. W. (1997): Opiates and infection. Adv. Neuroimmunol. (in press).
75. ROJAVIN M., SZABO R., BUSSIERE J. L., ROGERS T. J., ALDER M. W. and EISENSTEIN T. K. (1993): Morphine treatment in vitro or in vivo decrease phagocytic functions of murine macrophages. Life Sci., 53, 997-1006.
76. RUFF M. R., WAHL S. M., MERGENHAGEN S. and PERT C. B. (1985): Opiate receptor-mediated chemotaxis of human monocytes. Neuropeptides, 5, 363-366.
77. RUZICKA B. B., THOMPSON R. C., WATSON S. J. and AKIL H. (1996): Interleukin-1β-mediated regulation of μ-opioid receptor mRNA in primary astrocyte-enriched cultures. J. Neurochem., 66, 425-428.
78. SCOTT C. C. and CHEN K. K. (1946): The action of 1,1-diphenyl-1-(dimethylaminoisopropyl)-butanone-2, a potent analgesic agent. J. Pharmacol. Exp. Ther., 87, 63-71.
79. 3H]-etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. USA, 70, 1947-1949.
80. SOWA G., GEKKER G., HU S., LIPOVSKY M. M., CHAO C. C. and PETERSON P. K. (1997): Inhibition of swine microglial cell phagocytosis of Cryptococcus neoformans by morphine. Biochem. Pharmacol., 53, 823-828.
81. STIENE-MARTIN A., GURWELL J. A. and HAUSER K. F. (1991): Morphine alters astrocyte growth in primary cultures of mouse glial cells: evidence for a direct effect of opiates on neural maturation. Dev. Brain Res., 60, 1-7.
82. STIENE-MARTIN A. and HAUSER K. F. (1993): Morphine suppresses DNA synthesis in cultured murine astrocytes from cortex, hippocampus and streatum. Neurosci. Lett., 157, 1-3.
83. SUNDAR K. S., KAMARAJU L. S. MCMAHON J., BITONTE R. A., GOLLAPUDI S., WILSON W. H., KONG L.-Y., HONG J. S. and LEE J. E. (1996): Endogenous opioids and HIV infection. Adv. Exp. Med. Biol., 402, 53-57.
84. SZABO I., ROJAVIN M., BUSSIERE J. L., EISENSTEIN T. K., ADLER M. W. and ROGERS T. J. (1993): Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J. Pharmacol. Exp. Ther., 267, 703-706.
85. TEMPEL A. and ZUKIN R. S. (1987): Neuroanatomical patterns of μ, δ, and κ opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. USA, 84, 4308-4312.
86. TERENIUS L. (1973): Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of the rat cerebral cortex. Acta Pharmacol. Toxicol., 32, 317-320.
87. VAN EPPS E. E. and SALAND L. (1984): Beta-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J. Immunol., 132, 3046-3053.
88. 5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Sci., 31, 119-126.
89. VITKOVIC L., WOOD G. P., MAJOR E. O. and FAUCI A. S. (1991): Human astrocytes stimulate HIV-1 expression in a chronically infected promonocyte clone via interleukin-6. AIDS Res. Hum. Retroviruses, 7, 723-727.
90. WATKINS B. A., DORN H. H., KELLY W. B., ARMSTRONG R. C., POTTS B. J., MICHAELS F., KUFTA C. V. and DUBOIS-DALCQ M. (1990): Specific tropism of HIV-1 for microglial cells in primary human brain cultures. Science, 249, 549-553.
91. WIDMAYER M. A., TURNER T. D., BROWNING J. L. and BASKIN D. S. (1994): U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia. Mol. Chem. Neuropathol. 22, 211-223.
92. YASUDA K., RAYNOR K., KONG H., BREDER C. D., TAKEDA J., REISINE T. and BELL G. I. (1993): Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA, 90, 6736-6740.
93. ZADINA J. E., HACKLER L., GE L.-J. and KASTIN A. J. (1997): A potent and selective endogenous agonist for the μ-opiate receptor. Nature, 386, 499-502.
94. ZAGON I. S. and MCLAUGHLIN P. J. (1983): Increased brain size and cellular content in infant rats treated with an opiate antagonist. Science, 221, 1179-1180.
95. ZAGON I. S. and MCLAUGHLIN P. J. (1991): Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res., 542, 318-323.